Host: Mark Nolan Hill, MD

Guest: John Whittington, MD

One of the components of the Institute for Healthcare Improvement's Triple Aim initiative is to manage the per capita cost of healthcare. Is this an achievable goal? How do we get there? In this segment Dr. John Whittington, lead faculty of the Triple Aim Project discusses healthcare cost managment with host, Dr. Mark Nolan Hill.

Host: Mark Nolan Hill, MD

Guest: John Whittington, MD

In the first part of this interview, Dr. John Whittington talks with host Dr. Mark Nolan Hill about the history and initiatives of the Institute for Healthcare Improvement. In the second part of this segment he talks about Triple Aim: a healthcare challenge to improve the health of a defined population, improve the individual's healthcare experience, and manage the per capita cost of healthcare. Look for other Triple Aim Segments to Learn more.

Host: Susan Dolan, RN, JD

Guest: Donald Taylor, PhD

Hear Dr. Donald H. Taylor, Assistant Professor of Public Policy Studies at Duke University, as he discusses his research revealing that hospice saves Medicare money.

Host: Susan Dolan, RN, JD

Guest: Mary Labyak, MSW

Hear Mary Labyak, MSW, President and CEO of the Hospice of the Florida Suncoast, the largest not-for-profit, community based hospice in the nation, dispel myths about hospice.

Host: Maurice Pickard, MD

Guest: Maureen Bisognano, MS

Maureen Bisognano, Executive Vice President and Chief Operating Officer at the Institute for Healthcare Improvement, explores some of the theories of Dr. Noriaki Kano. In the healthcare industry the connections between quality and cost are not always clear. Mrs. Bisognano uses Dr. Kano's framework and demonstrates three ways that health care leaders can improve quality. She also speaks on the need to balance competing priorities and associated tensions between professionals of the healthcare and financial services respectively. Finally, Mrs. Bisognano describes new roles for physician leaders as they work to improve clinical and operational performance and achieve best financial outcomes.

Host: Maurice Pickard, MD

Guest: Maureen Bisognano, MS

How do quality improvements in health care yield strong returns on investment? Maureen Bisognano, executive vice president and chief operating officer of the Institute for Healthcare Improvement discusses how to get leadership to buy into better healthcare. She then outlines what the medical profession can learn from successful healthcare models that anticipate, rather than react to, changes in the field.

Host: Bill Rutenberg, MD

Guest: Charlene Harrington, RN, PhD

Professor and RN Charlene Harrington discuss the Future of Nursing Homes with host, Dr. Bill Rutenberg. What policies are vital to keep nursing homes up to snuff so they’re ready for the aging population? They also discuss the development of and usefulness of Nursing Home Consumer Information System, Reimbursement policies, and Regulation required in the nursing home industry.

Host: Bill Rutenberg, MD

Guest: Charlene Harrington, RN, PhD

Professor and RN, Charlene Harrington discusses with host Dr. Bill Rutenberg the recently launched UCSF demonstration project to design and test nursing interventions to improve quality of care in nursing homes. A focus of the study is to "refine a practice model to transform the nursing home care, based on peer-reviewed research into what works and what does not." Another goal of the study is to "translate the findings from the current research into practical changes on a national scale."

Host: Bill Rutenberg, MD

Guest: Richard Moss, MD

Our guest Dr. Rick Moss discuses with host, Dr. Bill Rutenberg current modes of diagnosis, including the genetic basis of CF. This is followed by a discussion of current and future treatments for cystic fibrosis, including lung transplantation, stem cell and gene therapies.

Host: Bill Rutenberg, MD

Guest: Richard Moss, MD

No longer a disease of childhood, patients with cystic fibrosis are now living well into adult life. Dr. Moss discusses with host Dr. Bill Rutenberg about the current state of the art of treatment that has made long-term survival possible, new morbidities resulting from increased survival to financing health care for adults with cystic fibrosis and transitioning from pediatric to adult care.